collaboration
MeiraGTx, Hologen Tackle CNS Disorders With AI Drug Development Joint Venture
Hologen is paying MeiraGTx $200 million upfront and committing $230 million to fund Hologen Neuro AI and a Parkinson's disease gene therapy.
ElevateBio Inks Deal to Use Amazon Web Services' AI Tools for CRISPR Drug Development
ElevateBio has entered into a multiyear collaboration with Amazon's cloud arm to identify treatment targets and new CRISPR systems.
Aprea, MD Anderson Partner to Study WEE1 Kinase Inhibitor in Certain Head and Neck Cancers
The collaboration will explore the potential of APR-1051 as a therapy for head and neck cancers bearing markers of replication stress.
CityUHK, Cellomics to Develop Circulating Tumor Cell Screening Platform
Within two years, the team hopes to commercialize an assay that combines cell sorting, staining, and imaging, as well as protein and gene profiling.
Tethis, Sheba Medical Center Trying to Predict Rectal Cancer Relapse Earlier With CTCs, ctDNA
Sheba researchers will use Tethis' technology to prepare patients' blood samples for circulating tumor cells and circulating tumor DNA analysis.